Blog

Sharesight20ASX top 20 ASX trades - 8th October 2019

by David Olsen, Senior Marketing Manager — Content/SEO, Sharesight | Oct 7th 2019
Disclaimer: The below article is for informational purposes only and does not constitute a product recommendation, or taxation or financial advice and should not be relied upon as such. Please check with your adviser or accountant to obtain the correct advice for your situation.

We're a day later with this week's update due to the public holiday in Australia Monday this week.

Last week Sharesight users jumped on medical small cap Actinogen Medical (ASX: ACW) after the company announced positive study results for their Alzheimer’s drug Xanamem. Some users also sold down Nufarm limited to realise some gains after the stock shot up 42% in the last week of September.

Top 20 ASX trades last week

Click for the full Sharesight20ASX:

Top20 ASX trades October 1st 2019)

Subscribe to Sharesight20 snapshots

Did you know you can receive Sharesight20 trading snapshots by email automatically? Subscribe here to always get the latest data when it's released.

Track your investment portfolio with Sharesight

Get access to Sharesight20 insights like this by tracking your investment portfolio with Sharesight. Built for the needs of investors like you:

Sign up for a FREE Sharesight account and get started tracking your investments today.

FURTHER READING

Data protection

5 ways Sharesight keeps your data safe

by Ben Clendon | Jun 22nd 2025

Here at Sharesight, we maintain constant vigilance around cyber security. In this blog, we discuss five ways Sharesight keeps your data safe.

IPOs

The investor's guide to IPOs: Risks, rewards and strategies

by Stephanie Stefanovic | Jun 20th 2025

Discover when to invest in IPOs, how to approach them strategically, and how Sharesight helps you track and optimise your performance.

ETF overlap

ETF overlap: How to uncover and manage hidden concentration risk

by Prashant Mohan | Jun 18th 2025

Understand ETF overlap and concentration risk through a real-world example — and see how Sharesight’s exposure report helps you uncover and avoid hidden risks.